Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,128
New position
Shares Held
14,127
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 72 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $20,247,336 across 16 Drug Manufacturers - Specialty & Generic names. ALVO ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
154,970 | $5,250,383 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
137,572 | $4,980,106 | |
| 3 | VTRS |
Viatris Inc
|
159,289 | $2,529,509 | |
| 4 | CRON |
Cronos Group Inc.
|
810,163 | $2,252,253 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
50,635 | $1,284,609 | |
| 6 | ZTS |
Zoetis Inc.
|
15,258 | $1,096,439 | |
| 7 | LQDA |
Liquidia Corp
|
10,758 | $857,735 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
12,240 | $424,360 |
All Filings in ALVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,128 | 14,127 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||